Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy

American Journal of Hematology,Volume 0, Issue ja, -Not available-.

Source: American Journal of Hematology - July 28, 2018 Category: Hematology Authors: Zdenek Racil , Eva Koritakova , Tomasz Sacha , Hana Klamova , Petra Belohlavkova , Edgar Faber , Delphine Rea , Ludmila Malaskova , Jirina Prochazkova , Daniela Zackova , Jaroslava Voglova , Joanna W ącław Source Type: research